Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

In vitro and other alternative approaches to developmental neurotoxicity testing (DNT).

Lein P, Silbergeld E, Locke P, Goldberg AM.

Environ Toxicol Pharmacol. 2005 May;19(3):735-44. doi: 10.1016/j.etap.2004.12.035. Epub 2005 Jan 25.

PMID:
21783550
2.

Interactions between neuroactive steroids and reelin haploinsufficiency in Purkinje cell survival.

Biamonte F, Assenza G, Marino R, D'Amelio M, Panteri R, Caruso D, Scurati S, Yague JG, Garcia-Segura LM, Cesa R, Strata P, Melcangi RC, Keller F.

Neurobiol Dis. 2009 Oct;36(1):103-15. doi: 10.1016/j.nbd.2009.07.001. Epub 2009 Jul 10.

PMID:
19595767
3.

Protein translation in synaptic plasticity: mGluR-LTD, Fragile X.

Waung MW, Huber KM.

Curr Opin Neurobiol. 2009 Jun;19(3):319-26. doi: 10.1016/j.conb.2009.03.011. Epub 2009 May 4. Review.

4.

Comparing cortisol, stress, and sensory sensitivity in children with autism.

Corbett BA, Schupp CW, Levine S, Mendoza S.

Autism Res. 2009 Feb;2(1):39-49. doi: 10.1002/aur.64.

5.

Developmental exposure to polychlorinated biphenyls interferes with experience-dependent dendritic plasticity and ryanodine receptor expression in weanling rats.

Yang D, Kim KH, Phimister A, Bachstetter AD, Ward TR, Stackman RW, Mervis RF, Wisniewski AB, Klein SL, Kodavanti PR, Anderson KA, Wayman G, Pessah IN, Lein PJ.

Environ Health Perspect. 2009 Mar;117(3):426-35. doi: 10.1289/ehp.11771. Epub 2008 Sep 12.

6.

Neuroligin-3-deficient mice: model of a monogenic heritable form of autism with an olfactory deficit.

Radyushkin K, Hammerschmidt K, Boretius S, Varoqueaux F, El-Kordi A, Ronnenberg A, Winter D, Frahm J, Fischer J, Brose N, Ehrenreich H.

Genes Brain Behav. 2009 Jun;8(4):416-25. doi: 10.1111/j.1601-183X.2009.00487.x. Epub 2009 Feb 11.

7.

Association between arginine vasopressin 1a receptor (AVPR1a) promoter region polymorphisms and prepulse inhibition.

Levin R, Heresco-Levy U, Bachner-Melman R, Israel S, Shalev I, Ebstein RP.

Psychoneuroendocrinology. 2009 Jul;34(6):901-8. doi: 10.1016/j.psyneuen.2008.12.014. Epub 2009 Feb 5.

PMID:
19195791
8.

Immune involvement in schizophrenia and autism: etiology, pathology and animal models.

Patterson PH.

Behav Brain Res. 2009 Dec 7;204(2):313-21. doi: 10.1016/j.bbr.2008.12.016. Epub 2008 Dec 24.

PMID:
19136031
9.

A national profile of the health care experiences and family impact of autism spectrum disorder among children in the United States, 2005-2006.

Kogan MD, Strickland BB, Blumberg SJ, Singh GK, Perrin JM, van Dyck PC.

Pediatrics. 2008 Dec;122(6):e1149-58. doi: 10.1542/peds.2008-1057.

PMID:
19047216
10.

Evidence for three subtypes of repetitive behavior in autism that differ in familiality and association with other symptoms.

Lam KS, Bodfish JW, Piven J.

J Child Psychol Psychiatry. 2008 Nov;49(11):1193-200. doi: 10.1111/j.1469-7610.2008.01944.x.

11.

Convulsing toward the pathophysiology of autism.

Tuchman R, Moshé SL, Rapin I.

Brain Dev. 2009 Feb;31(2):95-103. doi: 10.1016/j.braindev.2008.09.009. Epub 2008 Nov 8. Review.

12.

Exaggerated responses to stress in the BTBR T+tf/J mouse: an unusual behavioral phenotype.

Benno R, Smirnova Y, Vera S, Liggett A, Schanz N.

Behav Brain Res. 2009 Feb 11;197(2):462-5. doi: 10.1016/j.bbr.2008.09.041. Epub 2008 Oct 14.

PMID:
18977396
13.

Enantiomeric specificity of (-)-2,2',3,3',6,6'-hexachlorobiphenyl toward ryanodine receptor types 1 and 2.

Pessah IN, Lehmler HJ, Robertson LW, Perez CF, Cabrales E, Bose DD, Feng W.

Chem Res Toxicol. 2009 Jan;22(1):201-7. doi: 10.1021/tx800328u.

14.

Gene-environment interaction during early development in the heterozygous reeler mouse: clues for modelling of major neurobehavioral syndromes.

Laviola G, Ognibene E, Romano E, Adriani W, Keller F.

Neurosci Biobehav Rev. 2009 Apr;33(4):560-72. doi: 10.1016/j.neubiorev.2008.09.006. Epub 2008 Sep 20. Review.

PMID:
18845182
15.

Forebrain steroid levels fluctuate rapidly during social interactions.

Remage-Healey L, Maidment NT, Schlinger BA.

Nat Neurosci. 2008 Nov;11(11):1327-34. doi: 10.1038/nn.2200. Epub 2008 Sep 28.

16.

Oxytocin levels in social anxiety disorder.

Hoge EA, Pollack MH, Kaufman RE, Zak PJ, Simon NM.

CNS Neurosci Ther. 2008 Fall;14(3):165-70. doi: 10.1111/j.1755-5949.2008.00051.x.

PMID:
18801109
17.

In vitro biologic activities of the antimicrobials triclocarban, its analogs, and triclosan in bioassay screens: receptor-based bioassay screens.

Ahn KC, Zhao B, Chen J, Cherednichenko G, Sanmarti E, Denison MS, Lasley B, Pessah IN, Kültz D, Chang DP, Gee SJ, Hammock BD.

Environ Health Perspect. 2008 Sep;116(9):1203-10. doi: 10.1289/ehp.11200.

18.

Unusual repertoire of vocalizations in the BTBR T+tf/J mouse model of autism.

Scattoni ML, Gandhy SU, Ricceri L, Crawley JN.

PLoS One. 2008 Aug 27;3(8):e3067. doi: 10.1371/journal.pone.0003067.

19.

Establishment of "The Gene Mine": a resource for rapid identification of complex trait genes.

Morahan G, Balmer L, Monley D.

Mamm Genome. 2008 Jun;19(6):390-3. doi: 10.1007/s00335-008-9134-9. Epub 2008 Aug 21.

PMID:
18716834
20.

The Collaborative Cross at Oak Ridge National Laboratory: developing a powerful resource for systems genetics.

Chesler EJ, Miller DR, Branstetter LR, Galloway LD, Jackson BL, Philip VM, Voy BH, Culiat CT, Threadgill DW, Williams RW, Churchill GA, Johnson DK, Manly KF.

Mamm Genome. 2008 Jun;19(6):382-9. doi: 10.1007/s00335-008-9135-8. Epub 2008 Aug 21.

Supplemental Content

Support Center